Multifunctional Diamine AGE/ALE Inhibitors With Promising Properties for Treating Alzheimer's Disease

doi 10.3390/ecmc-3-04655

Full Text

Abstract

Available in

Date

Authors

Publisher

MDPI

Related search

Proteinase Inhibitors: A Promising Drug Class for Treating Leishmaniasis

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2014English

Platinum-Based Inhibitors of Amyloid- As Therapeutic Agents for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy

Frontiers in Pharmacology
Pharmacology
2018English

G-Secretase/Presenilin Inhibitors for Alzheimer's Disease Phenocopy Notch Mutations in Drosophila

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
2002English

624. Immunovirotherapy Combined With Immune Checkpoint Inhibitors for Treating Glioblastoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2011English

Are We Over-Treating With Checkpoint Inhibitors?

British Journal of Cancer
Cancer ResearchOncology
2019English

CHRNA7 Polymorphisms and Response to Cholinesterase Inhibitors in Alzheimer's Disease

PLoS ONE
Multidisciplinary
2013English

Use of Cholinesterase Inhibitors Increases Initiation of Urinary Anticholinergics in Persons With Alzheimer's Disease

Journal of the American Geriatrics Society
GerontologyGeriatrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy